Evidence-Based Precision Oncology with the Cancer Targetome.

ABSTRACT: A core tenet of precision oncology is the rational choice of drugs to interact with patient-specific biological targets of interest, but it is currently difficult for researchers to obtain consistent and well-supported target information for pharmaceutical drugs. We review current drug-target interaction resources and critically assess how supporting evidence is handled. We introduce the concept of a unified Cancer Targetome to aggregate drug-target interactions in an evidence-based framework. We discuss current unmet needs and the implications for evidence-based clinical omics. The focus of this review is precision oncology but the discussion is highly relevant to targeted therapies in any area.

SUBMITTER: Blucher AS 

PROVIDER: S-EPMC5759325 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature